Liver Diseases  >>  Daklinza (daclatasvir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Daklinza (daclatasvir) / BMS
NCT00859053: Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

Completed
1
46
US
BMS-790052
Bristol-Myers Squibb
Hepatic Insufficiency
09/09
09/09
NCT00983957: Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

Checkmark
Dec 2013 - Dec 2013: 
Completed
1
47
US, Canada
BMS-790052, Ortho Tri-Cyclen®
Bristol-Myers Squibb
Chronic Hepatitis C
02/10
02/10
NCT01830205: Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment

Checkmark VHC 2014
Oct 2014 - Oct 2014: VHC 2014
Checkmark ACG 2014
Sep 2014 - Sep 2014: ACG 2014
Completed
1
58
US
Daclatasvir, BMS-790052
Bristol-Myers Squibb
Hepatitis C
06/13
06/13
NCT02159352: Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Completed
1
49
US
Daclatasvir, BMS-790052, Darunavir, Prezista, Ritonavir, Norvir, Lopinavir/Ritonavir
Bristol-Myers Squibb
Hepatitis C
07/14
07/14

Download Options